Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fluorodeoxyglucose”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03015298
What this trial is testing

Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer

Who this might be right for
Gastric Cancer Stage
Chinese PLA General Hospital 100
Not applicableActive Not RecruitingNCT00194298
What this trial is testing

FDG-PET Imaging in Complicated Diabetic Foot

Who this might be right for
Diabetic Foot Disease
University of Pennsylvania 240
Not applicableUnknownNCT06260982
What this trial is testing

Cognitive Disorders in Hereditary Spastic Paraplegia Type 4

Who this might be right for
Spastic Paraplegia
Central Hospital, Nancy, France 30
Not applicableEnrolling By InvitationNCT05160480
What this trial is testing

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

Who this might be right for
Prostate CancerBreast CancerNeuroendocrine Tumors
University of California, Davis 9
Not applicableActive Not RecruitingNCT03370614
What this trial is testing

Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Thomas Jefferson University 50
Not applicableStudy completedNCT05113576
What this trial is testing

Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 132
Not applicableStudy completedNCT01800032
What this trial is testing

PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)

Who this might be right for
Neurofibromatosis-1Optic GliomaPlexiform Neurofibroma
UNC Lineberger Comprehensive Cancer Center 30
Not applicableWithdrawnNCT02919332
What this trial is testing

Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioma
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT01691300
What this trial is testing

C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT

Who this might be right for
Multiple Myeloma
Chang Gung Memorial Hospital 30
Not applicableUnknownNCT02391246
What this trial is testing

Radionecrosis and FDG PET

Who this might be right for
Malignant Glioma
Ottawa Hospital Research Institute 62
Not applicableStudy completedNCT02180308
What this trial is testing

Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI

Who this might be right for
Head and Neck Cancer
NYU Langone Health 23
Early research (Phase 1)Looking for participantsNCT05747625
What this trial is testing

(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaStage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck
Eben Rosenthal 60
Not applicableStudy completedNCT06919159
What this trial is testing

Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate-specific Membrane AntigenPositron Emission Tomography (PET)
Jiequn Yu 45
Not applicableEnded earlyNCT02847468
What this trial is testing

Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Who this might be right for
Carcinoma, Hepatocellular
Centre Georges Francois Leclerc 61
Post-approval studies (Phase 4)Study completedNCT04183868
What this trial is testing

Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study)

Who this might be right for
Type 2 DiabetesCardiovascular Risk Factor
University of Catanzaro 26
Early research (Phase 1)Study completedNCT00959582
What this trial is testing

Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Merck Sharp & Dohme LLC 42
Testing effectiveness (Phase 2)UnknownNCT00199680
What this trial is testing

Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer

Who this might be right for
Cervical Cancer
University Hospital, Limoges 42
Not applicableUnknownNCT02855190
What this trial is testing

Comparative Study With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection

Who this might be right for
Infection and Inflammatory Reaction Due to Internal Joint Prosthesis
Chang Gung Memorial Hospital 30
Not applicableStudy completedNCT01218191
What this trial is testing

Acute Neurocardiogenic Injury After Subarachnoid Hemorrhage.

Who this might be right for
Subarachnoid Hemorrhage
Direction Centrale du Service de Santé des Armées 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06416852
What this trial is testing

Clinical Study of 18F-Alfatide Injection PET/CT

Who this might be right for
Non-Small Cell Lung Cancer NSCLC
Yantai LNC Biotechnology Singapore PTE. LTD. 428
Next Page